Eli Lilly’s Zepbound eases obstructive sleep apnea in trials
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
This cluster randomized clinical trial evaluates the implementation of a peer-to-peer support program to reduce psychological distress and posttraumatic stress disorder among patient-facing health care…
People across the country claim cancer-causing emissions from local sterilizing plants are making them sick. Southwest Memphis is no exception.
The Department of Labor (DOL) will release a final rule that completely overturns a Trump-era policy allowing small businesses to skirt the Affordable Care Act…
Delivering home urinalysis and digitized wound care in minutes
Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus…
The Department of Veterans Affairs has long given vets who served in Vietnam disability compensation for illness connected to Agent Orange harm. But those exposed…
Objectives Pharmacovigilance databases play a critical role in monitoring drug safety. The duplication of reports in pharmacovigilance databases, however, undermines their data integrity. This scoping…
Digital health is poised to revolutionize the field of oncology, offering innovative solutions that enhance diagnostics, treatment, and patient care. This comprehensive review delves into…
Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many…
A psychologist explains code-switching — what it is, why we do it and the ways it can both benefit and harm our mental health.